North Carolina Medicaid Expedited, Off-Cycle Reverification: What Providers and Transaction Parties Should Know

Key Takeaways

• North Carolina Medicaid has launched expedited, off-cycle reverification for certain CMS-designated high-risk providers, creating new enrollment and compliance deadlines outside the standard five-year cycle.
• Healthcare transaction parties should add Medicaid reverification status to pre-closing diligence, because a target may remain actively enrolled while facing a provider-specific reverification deadline.
• Missed reverification deadlines may create reimbursement, valuation, and closing risk, making NCTracks notices and the North Carolina Department of Health and Human Services (“NCDHHS”) reverification report important diligence items between signing and closing.

North Carolina Medicaid has announced an expedited, off-cycle reverification initiative for certain high-risk providers, creating a potentially significant enrollment and transaction-diligence consideration for providers and health care companies participating in North Carolina Medicaid.

On September 10, 2026, NCDHHS posted its September 2026 Active Provider Reverification Report, which identifies providers scheduled for Medicaid reverification. The report includes a “CMS_HighRisk_Atypical” tab identifying providers selected for an expedited, off-cycle reverification initiative requested by the Centers for Medicare & Medicaid Services (“CMS”). The initiative applies to providers participating in both North Carolina Medicaid Managed Care and North Carolina Medicaid Direct.

The initiative is particularly relevant in healthcare transactions because a provider may remain listed as active in Medicaid while also being subject to an expedited reverification process that may result in a provider-specific application deadline. For a target whose North Carolina Medicaid enrollment supports a material portion of its revenue, an adverse enrollment development between signing and closing could have consequences extending well beyond ordinary provider-enrollment compliance.

What Is North Carolina’s Expedited Medicaid Reverification Initiative?

CMS notified North Carolina in April 2026 that the state should conduct an off-cycle, expedited provider reverification process focused on certain high-risk providers, including atypical providers. NCDHHS subsequently announced that affected providers would be identified in the Active Provider Reverification Report under the CMS_HighRisk_Atypical tab.

The tab includes providers classified at the high categorical risk level that meet at least one of two criteria:

1. the provider has not undergone reverification within the preceding 12 months; or
2. the provider is otherwise due for reverification within the next 12 months.

This initiative is separate from the ordinary five-year Medicaid recredentialing cycle. For providers selected for the expedited process, the state is requiring an additional enrollment review on a timeline that may not correspond with the provider’s ordinary reverification cycle, with individual instructions and deadlines expected through NCTracks.

How Medicaid Reverification May Affect Healthcare Transactions

A target may be active in North Carolina Medicaid at signing but receive an expedited reverification notice before closing. If the provider does not respond timely, its Medicaid participation could be suspended during the period between signing and closing.

Depending on the target’s payor mix and business model, an adverse reverification development could affect:

• Revenue, cash flow, and valuation: A suspension may interrupt Medicaid reimbursement and affect financial projections, valuation, and financing assumptions.
• Transaction representations and bring-down: A pending reverification, suspension, or other adverse enrollment development could implicate representations concerning governmental-program participation, compliance, licenses, permits, and material contracts.
• Closing protections: The parties may consider a covenant to complete the process, enhanced interim reporting, or a closing condition where Medicaid revenue is material.
• Post-closing enrollment planning: The buyer should evaluate whether the transaction or changes to ownership and managing relationships require additional enrollment actions.

A provider that does not timely submit required materials may have its provider record suspended. A prolonged or unsuccessful reverification process can create a risk of termination and may require re-enrollment.

Affected providers therefore should treat any reverification notice as a time-sensitive enrollment matter, rather than a routine administrative request.

What North Carolina Medicaid Providers and Transaction Parties Should Do Now

NCDHHS has indicated that providers identified through the CMS_HighRisk_Atypical initiative will receive notices containing specific application deadlines by the end of September 2026. NCDHHS is also holding a provider enrollment webinar addressing reverification and related enrollment issues on September 24, 2026.

Providers should review the September report and monitor NCTracks for individual notices. For transaction parties, the key takeaway is that current active Medicaid status should not be treated as the final word on enrollment risk. A pending reverification obligation may affect operations, reimbursement, and closing risk during the period between signing and closing.

The Arnall Golden Gregory Change of Ownership (“CHOW”) team leads all regulatory aspects of healthcare transactions for investors, operators, managers, capital partners, and developers of every size in all 50 states. The team streamlines the regulatory process so that clients close their transactions on or ahead of schedule. Whether obtaining licensure and Medicare/Medicaid approvals, structuring transactions to expedite closings, anticipating issues to minimize cash flow disruption, negotiating regulatory terms in deal documents, creatively resolving diligence issues, or advising on CHOW guidelines and compliance, the team provides extensive experience and practical solutions. To date, the CHOW team has served as primary regulatory counsel in transactions valued at more than $35 billion.​​